Rishab Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.23 Cr
as on 24-10-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 37.95%
(FY 2023)
- Profit 61.48%
(FY 2023)
- Ebitda 47.77%
(FY 2023)
- Net Worth 6.39%
(FY 2023)
- Total Assets 40.60%
(FY 2023)
About Rishab Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Raj Jain, Poonam Jain, and Chander Shankar serve as directors at the Company.
- CIN/LLPIN
U51397CH2005PTC027979
- Company No.
027979
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rishab Healthcare Private Limited offer?
Rishab Healthcare Private Limited offers a wide range of products and services, including API Intermediate, Eyewear, Sun Glasses, Antipyretic Medication, Paracetamol Tablets, Aceclofenac Tablet, Aceclofenac Thiocolchicoside Tablets, Health Conditions, Liver Care, Stomach Care.
Who are the key members and board of directors at Rishab Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Jain  | Director | 16-Feb-2005 | Current |
| Poonam Jain | Director | 16-Feb-2005 | Current |
| Chander Shankar | Additional Director | 31-May-2016 | Current |
Financial Performance of Rishab Healthcare.
Rishab Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.95% increase. The company also saw a substantial improvement in profitability, with a 61.48% increase in profit. The company's net worth moved up by a moderate rise of 6.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rishab Healthcare?
Unlock access to Rishab Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rishab Healthcare?
Unlock and access historical data on people associated with Rishab Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rishab Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rishab Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
